Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

NCT03080883 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

370

Enrollment

OTHER

Sponsor class

Conditions

Cerebral Vein Thrombosis
Deep Vein Thrombosis
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
Pulmonary Embolism
Splanchnic Vein Thrombosis

Interventions

DRUG: Apixaban

Sponsor

Academic and Community Cancer Research United

Collaborators

[object Object]